Bone Biologics's total assets for Q were $3.84M, an increase of 2.72% from the previous quarter. BBLG total liabilities were $164.63K for the fiscal quarter, a -80.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.